论文部分内容阅读
目的观察痰热清在慢性阻塞性肺疾病(COPD)急性加重期中的治疗作用。方法COPD急性加重期患者126例,在常规抗感染、氧疗的基础上,用痰热清注射液治疗,比较治疗前及治疗后4、8日症状评分,并判定疗效。结果治疗后咳嗽、咳痰、痰粘度和发热等症状均明显改善,总有效率均在90%以上,对喘息的有效率也达72·3%;所有患者均未发现严重的不良反应。结论痰热清具有抗菌、止咳、化痰、解痉平喘和退热等作用,可安全有效改善COPD急性加重期患者的症状。
Objective To observe the therapeutic effect of Tanreqing on acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods A total of 126 patients with acute exacerbation of COPD were treated with Tanreqing injection on the basis of routine anti-infective and oxygen therapy. Symptom scores were compared before treatment and on the 4th and 8th day after treatment, and the curative effect was evaluated. Results The symptoms of cough, sputum, sputum viscosity and fever were significantly improved after treatment. The total effective rate was above 90% and the effective rate of breathing was 72.3%. No serious adverse reactions were found in all patients. Conclusion Tanreqing has antibacterial, antitussive, phlegm, antispasmodic and antipyretic effects, which can effectively and safely ameliorate the symptoms of patients with acute exacerbation of COPD.